Skip to main content

Psoriatic arthritis

      RT @uptoTate: Pregnant pts w/ PsA, but not AxSpA, at increased risk of pre-eclampsia. In RA pregnancies, pre-eclampsia r
      3 years 1 month ago
      Pregnant pts w/ PsA, but not AxSpA, at increased risk of pre-eclampsia. In RA pregnancies, pre-eclampsia risk increases w/ dz severity prior/during pregnancy. We need to discuss potential risks w/ pts and OB team. Abs 1722 #ACR21 #RheumNow @RheumNow https://t.co/yeQmNAZ1jV https://t.co/cBfeVKQHfr
      RT @uptoTate: The wave of the future? Study details immune profile which discriminates PsA from PsO using phenotyping of
      3 years 1 month ago
      The wave of the future? Study details immune profile which discriminates PsA from PsO using phenotyping of serum immune cell subsets & machine learning. Abs 1774 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/huNTY3IdRf https://t.co/3aW64pb9UW
      RT @DrPetryna: Abst1783 #ACR21 #ACRBest @RheumNow Canadian study reports promising trends on hospitalizations for seriou
      3 years 1 month ago
      Abst1783 #ACR21 #ACRBest @RheumNow Canadian study reports promising trends on hospitalizations for serious infections in PsA: 2012 – 2017 statist signif ⬇️ in discharges for sepsis, skin & soft tissue infect & UTI (p < 0.001 for all). no statistical difference in the trend of PNA https://t.co/lqtCzUFPAW
      RT @doctorRBC: Upadacitinib showed similar efficacy in AS pts compared to PsA pts with axial involvement
      ⭐️PsA pt w/
      3 years 1 month ago
      Upadacitinib showed similar efficacy in AS pts compared to PsA pts with axial involvement ⭐️PsA pt w/ axial involvement and AS pts with differences in baseline characteristics #ACR21 @RheumNow Abs#1802 https://t.co/QvyayelBYU https://t.co/50dNQm30vf
      RT @DrMiniDey: Excellent overview on assessment of patients with #PsA by @AlexisOgdie!
      Really clear and easy-to-follow s
      3 years 1 month ago
      Excellent overview on assessment of patients with #PsA by @AlexisOgdie! Really clear and easy-to-follow slides to add structure to clinical assessment. #ACR21 @RheumNow https://t.co/XGZrCxOukm
      RT @RHEUMarampa: Fr AQUILA study: #Uveitis status in AS or PsA pts given SEC
      👁‍🗨3 pts w/o uveitis at BL develope
      3 years 1 month ago
      Fr AQUILA study: #Uveitis status in AS or PsA pts given SEC 👁‍🗨3 pts w/o uveitis at BL developed new onset uveitis during study 👁‍🗨Most pts w/uveitis at BL - status remained unchanged or improved 👁‍🗨SEC did not ⬆ risk of uveitis @RheumNow #ACR21 abs1738 https://t.co/IGUpgXBLvt
      RT @RichardPAConway: No benefit to using MTX in combination with ustekinumab in PsA. No difference in efficacy for arthr
      3 years 1 month ago
      No benefit to using MTX in combination with ustekinumab in PsA. No difference in efficacy for arthritis, enthesitis, dactylitis, skin, QoL or function. Abstr#L12 #ACR21 @RheumNow https://t.co/iojKLqRb06
      RT @uptoTate: Clinical and research pearl: SPACC vs LEEDs enthesitis scoring for your PsA patients by Dr. Ogdie. #ACR21
      3 years 1 month ago
      Clinical and research pearl: SPACC vs LEEDs enthesitis scoring for your PsA patients by Dr. Ogdie. #ACR21 @RheumNow #RheumNow https://t.co/dDznwSicRQ
      RT @synovialjoints: Isolated axial involvement exists in 2-5% of PsA patients. In 576 patients 495 (31.4%) had axial dis
      3 years 1 month ago
      Isolated axial involvement exists in 2-5% of PsA patients. In 576 patients 495 (31.4%) had axial disease, of which 32 (2.0%) had isolated axial disease. HLA-B*27+ and lower HAQ scores were associated with isolated axial disease @RheumNow #ACR21 Abst#1775 https://t.co/Y1EAJlA0mT https://t.co/8oZhN3mT30
      RT @RichardPAConway: Dr Deike on prevalence and incidence of PsA in Germany. Prevalence 5-6/1000. Incidence 30-40/100000
      3 years 1 month ago
      Dr Deike on prevalence and incidence of PsA in Germany. Prevalence 5-6/1000. Incidence 30-40/100000. Marked age variations that don't really make sense for prevalence. Abstr#1785 #ACR21 @RheumNow https://t.co/uW0ruW2Jda
      ×